David Jung

2.6k citations

35 papers · 1.5k indexed · h-index 21

Impact in

Microbiology top 2%
- Antimicrobial Peptides and Activities
Molecular Medicine top 5%

Papers in

Molecular Medicine 6
- Antibiotic Resistance in Bacteria 6
Microbiology 6
- Antimicrobial Peptides and Activities 6

Co-authors: Robert E. W. Hancock Mark Okon Annett Rozek Samuel J. Danishefsky John J. Masters Martin J. Di Grandi Suzana K. Straus William G. Bornmann
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of the American Chemical Society (3 papers)Organic Letters (2 papers)Journal of Membrane Science (2 papers)Molecular Microbiology (1 paper)
Partner nations: United States Canada Germany

In The Last Decade

David Jung

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by David Jung

Since Specialization

Citations

This map shows the geographic impact of David Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jung more than expected).

Fields of papers citing papers by David Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jung. The network helps show where David Jung may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Jung Line = papers co-authored together David Jung links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	2-Aminoimidazole Analogs Target PhoP Altering DNA Binding Activity and Affect Outer Membrane Stability in Gram-Negative Bacteria Biochemistry ·Tonya N. Zeczycki, ChengXiang Xiang, David Jung, Richele J. Thompson, 深雪小川, Сергій Іванович Похил, Swari Dewanti Hamastuti, Christian Melander, John Cavanagh	2022	3
2	What Was the Name of That Drug? How Medical Students can Make the Most Out of Their Education SHILAP Revista de lepidopterología ·E. Graziani, David Jung	2019	1
3	How safe are our studies? Analysis of adverse events in Bayer First-in-Human trials from 2006 to 2016 International Journal of Clinical Pharmacology and Therapeutics ·David Jung, Ch Chethan Raj, Joseph Calcagno	2019	2
4	Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions between 2-Aminoimidazoles and the Response Regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp. Frontiers in Molecular Biosciences ·ChengXiang Xiang, 円香上村, Danni L. Harris, Brian Kang, David Jung, Manon Ortoli, Richele J. Thompson, Roberta J. Melander, Daina Zeng, Christian Melander, John Cavanagh	2018	23
5	New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii ACS Infectious Diseases ·円香上村, David Jung, Roberta J. Melander, Christian Melander	2018	32
6	Abstract 15196: A Novel Balanced Dual Vasopressin V1a/V2 Receptor Antagonist for Treatment of Congestive Heart Failure: Results From a First-in-Man Study Circulation ·Eduardo Pimenta, Markus Jensen, David Jung, Maximilian T. Lobmeyer, Walter Schmitt, Frank Schaumann, I. S. Balogh, Hubert Truebel	2017	1
7	The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mui Cheung, Philip A. Harris, Joy Ugo, Weiyuan Jin, Stanley D. Chamberlain, Rosanne Tackaberry, David Jung, Stephanie Harris, G. Vaikutien, Andrea H. Epperly, Stephen A. Stimpson, Michael Peel	2008	36
8	NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles Biochimica et Biophysica Acta (BBA) - Biomembranes ·Walter R. P. Scott, Seung Bin Baek, David Jung, Robert E. W. Hancock, Suzana K. Straus	2007	54
9	Effect of divalent cations on the structure of the antibiotic daptomycin European Biophysics Journal ·Lee Jaemyon, David Jung, Jennifer R. Calhoun, James D. Lear, Mark Okon, Walter R. P. Scott, Robert E. W. Hancock, Suzana K. Straus	2007	90
10	Discovery and in vitro Evaluation of Potent Kinase Inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4‐d]pyrimidines. ChemInform ·Rosanne Tackaberry, بدر محمد محمود حمودة, Karen Lackey, Octerloney B. McDonald, Edgar R. Wood, Frank Preugschat, Geoffrey J. Cutler, Laurie S. Kane-Carson, Wei Liu, David Jung	2006	1
11	(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark J. Bamford, Rosanne Tackaberry, Nicholas Bailey, Susannah Davies, David K. Dean, Alessandra Gaiba, Stephen L. Garland, John D. Harling, David Jung, Вельмяйкин Иван Николаевич, Christopher A. Parr, Jon G.A. Steadman, Andrew K. Takle, James T. Townsend, David M. Wilson, Jason Witherington	2005	30
12	Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines Bioorganic & Medicinal Chemistry Letters ·Rosanne Tackaberry, بدر محمد محمود حمودة, Karen Lackey, Octerloney B. McDonald, Edgar R. Wood, Frank Preugschat, Geoffrey J. Cutler, Laurie S. Kane-Carson, Wei Liu, David Jung	2005	28
13	Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors Organic Letters ·Kirk L. Stevens, David Jung, Rosanne Tackaberry, Joy Ugo, Weiyuan Jin, Wu Fa Cai, Mui Cheung, Philip A. Harris, Stanley D. Chamberlain, Michael Peel	2005	73
14	Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin Chemistry & Biology ·David Jung, Annett Rozek, Mark Okon, Robert E. W. Hancock	2004	231
15	Auto-Titrating Versus Standard Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnea: Results of a Meta-analysis SLEEP ·Najib Ayas, Sanjay R. Patel, Atul Malhotra, Michael Schulzer, Mark Malhotra, David Jung, John A. Fleetham, David P. White	2004	154
16	Pyrazolo[1,5-a]pyridines: synthetic approaches to a novel class of antiherpetics Tetrahedron ·Brian A. Johns, Kristjan S. Gudmundsson, Elizabeth M. Turner, Scott H. Allen, David Jung, Connie J. Sexton, F. Leslie Boyd, Michael Peel	2003	48
17	Identification and Structure–Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Stafford, Gregory J. Pacofsky, Richard F. Cox, Jill R. Cowan, Efraín Aedo Yanqui, Stephen S. Gonzales, David Jung, George W. Koszalka, Maggie S. McIntyre, Jeffrey H. Tidwell, Robert P. Wiard, Paul L. Feldman	2002	24
18	Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430: A Remarkably Stereo- and Regioselective Synthesis of Mixed Tetrahydroisoquinolinium Chlorofumarates Organic Letters ·Vicente Sámano, John A. Ray, James B. Thompson, Robert A. Mook, David Jung, Cecilia S. Koble, Michael T. Martin, Eric C. Bigham, И. Н. Ким, Paul L. Feldman, Eric E. Boros	1999	30
19	Eine neuartige, intramolekulare Heck‐Reaktion: Synthese eines Cholesterin‐Baccatin‐III‐Hybrids Angewandte Chemie ·John J. Masters, David Jung, Samuel J. Danishefsky, Lawrence B. Snyder, Tae Kyo Park, Richard C.A. Isaacs, Cheryl A. Alaimo, Wendy B. Young	1995	4
20	A total synthesis of (.+-.)-bilobalide. Journal of the American Chemical Society ·Michael T. Crimmins, David Jung, Jeffrey J. Gray	1992	25

About David Jung

David Jung is a scholar working on Molecular Medicine, Microbiology, Organic Chemistry, Statistics and Probability and Molecular Biology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (6 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (4 papers), Synthesis and biological activity (3 papers), Synthesis and Reactivity of Heterocycles (3 papers), Melanoma and MAPK Pathways (3 papers), Chemical Synthesis and Analysis (3 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Microbiology (191 citations), Molecular Medicine (122 citations), Organic Chemistry (652 citations), Endocrine and Autonomic Systems (132 citations) and Pharmacology (234 citations). David Jung has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert E. W. Hancock, Mark Okon, Annett Rozek, Samuel J. Danishefsky, John J. Masters, Martin J. Di Grandi, Suzana K. Straus, William G. Bornmann, Cheryl A. Alaimo and Wendy B. Young. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Organic Letters, Journal of Membrane Science and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact